Dr Amy Watson joins Ethics Talk to discuss how crisis intervention teams can motivate efficiency and equity in tactical responses to 911 calls and what community mental health intervention might look like when we think beyond the limits of law enforcement response.
Carlos Martinez, MPH, Lauren Carruth, PhD, Hannah Janeway, MD, Lahra Smith, PhD, Katharine M. Donato, PhD, Carlos Piñones-Rivera, PhD, James Quesada, PhD, and Seth M. Holmes, MD, PhD
Transnational violence has been created by international policy, militaristic interventions, and multinational organizational administration of border operations.
AMA J Ethics. 2022;24(4):E275-282. doi:
10.1001/amajethics.2022.275.
José G. Pérez Ramos, PhD, MPH, Adriana Garriga-López, PhD, and Carlos E. Rodríguez-Díaz, PhD, MPH
Hurricane María, earthquakes, the COVID-19 pandemic, and relentless privatization and fragmentation of the health care system have led to very poor health outcomes.
AMA J Ethics. 2022;24(4):E305-312. doi:
10.1001/amajethics.2022.305.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
COVID-19 underscores historical precedent for fear-driven responses that disregard autonomy among persons with low income who are also persons of color.
AMA J Ethics. 2021;23(11):E840-846. doi:
10.1001/amajethics.2021.840.